COVID-19 and immunosuppressive therapy in dermatology

被引：6

作者：

Schwartz, Robert A. ^{[1
]}

Pradhan, Swetalina ^{[2
]}

Murrell, Dedee F. ^{[3
]}

Jafferany, Mohammad ^{[4
]}

Olisova, Olga Y. ^{[5
]}

Lomonosov, Konstantin M. ^{[5
]}

Lotti, Torello ^{[5
,6
]}

Goldust, Mohamad ^{[7
,8
]}

机构：

[1] Rutgers New Jersey Med Sch, Dept Dermatol, Newark, NJ USA

[2] All India Inst Med Sci, Dept Dermatol & Venereol, Patna, Bihar, India

[3] Univ New South Wales, St George Hosp, Dept Dermatol, Fac Med, Sydney, NSW, Australia

[4] Cent Michigan Univ, Coll Med, Saginaw, MI USA

[5] IM Sechenov First Moscow State Med Univ, Dept Dermatol & Venereol, Moscow, Russia

[6] Univ Studies Guglielmo Marconi, Dept Dermatol, Rome, Italy

[7] Univ Studies Guglielmo Marconi, Rome, Italy

[8] Univ Hosp Basel, Dept Dermatol, Basel, Switzerland

来源：

DERMATOLOGIC THERAPY | 2020年 / 33卷 / 06期

关键词：

COVID; 19; dermatology; immunosuppressive therapy; ATOPIC-DERMATITIS; DIAGNOSIS;

D O I：

10.1111/dth.14140

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Coronavirus 2019 (COVID 19) was first detected in December 2019 in China. It has become a pandemic. With concern about therapies that may decrease immunity and enhance the severity of an individual's COVID-19 infection, leading to a possibly fatal outcome, use of immunosuppressants has become an important concern. This work focuses on management of various skin diseases individuals lacking immunity to COVID-19 but requiring a systemic immunosuppressant, keeping in view the challenge of the COVID 19 pandemic and that our knowledge of this virus and its effects on the immune system are incomplete including knowledge as to an individual's immunity after COVID-19 infection.

引用

页数：6

共 50 条

[1] COVID-19 and dermatology
Gul, Ulker
TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 (08) : 1751 - 1759
[2] Dermatology COVID-19 Registries Updates and Future Directions
Freeman, Esther E.
Chamberlin, Grace C.
McMahon, Devon E.
Hruza, George J.
Wall, Dmitri
Meah, Nekma
Sinclair, Rodney
Balogh, Esther A.
Feldman, Steven R.
Lowes, Michelle A.
Marzano, Angelo, V
Naik, Haley B.
Castelo-Soccio, Leslie
Lara-Corrales, Irene
Cordoro, Kelly M.
Mahil, Satveer K.
Griffiths, Christopher E. M.
Smith, Catherine H.
Irvine, Alan D.
Spuls, Phyllis, I
Flohr, Carsten
French, Lars E.
DERMATOLOGIC CLINICS, 2021, 39 (04) : 575 - 585
[3] Challenges of COVID-19 pandemic for dermatology
Wollina, Uwe
DERMATOLOGIC THERAPY, 2020, 33 (05)
[4] COVID-19 Vaccination and Immunosuppressive Therapy in Immune-Mediated Inflammatory Diseases
Serra Lopez-Matencio, Jose M.
Vicente-Rabaneda, Esther F.
Alanon, Estefania
Aranguren Oyarzabal, Ainhoa
Martinez Fleta, Pedro
Castaneda, Santos
Maggi, Fabrizio
Bordi, Licia
VACCINES, 2023, 11 (12)
[5] Dermatology practice in the times of the COVID-19 pandemic
Vashisht, Deepak
Neema, Shekhar
Venugopalan, Ruby
Pathania, Vikas
Sandhu, Sunmeet
Vasudevan, Biju
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2021, 87 (05) : 603 - 610
[6] Noncutaneous considerations of COVID-19 for dermatology practices
Ali, Faisal R.
Al-Niaimi, Firas
JOURNAL OF COSMETIC DERMATOLOGY, 2020, 19 (07) : 1544 - 1544
[7] The Impact of the COVID-19 Pandemic on Global Health Dermatology
Hannah, Claire
Williams, Victoria
Fuller, Lucinda Claire
Forrestel, Amy
DERMATOLOGIC CLINICS, 2021, 39 (04) : 619 - 625
[8] Impact of COVID-19 pandemic on dermatology practice in India
Bhargava, Shashank
Sarkar, Rashmi
INDIAN DERMATOLOGY ONLINE JOURNAL, 2020, 11 (05) : 712 - 719
[9] Clinical Patter ns and Morphology of COVID-19 Dermatology
Agnihothri, Ritesh
Fox, Lindy P.
DERMATOLOGIC CLINICS, 2021, 39 (04) : 487 - 503
[10] Editorial: The impact of the COVID-19 pandemic on dermatology patients: diagnosis, treatment, and prognosis
Huang, Huining
Guo, Ziyu
Chen, Danyao
Deng, Guangtong
FRONTIERS IN MEDICINE, 2024, 11

← 1 2 3 4 5 →